| Literature DB >> 34941762 |
Annisa Utami Rauf1, Anwar Mallongi1, Kiyoung Lee2, Anwar Daud1, Muhammad Hatta3, Wesam Al Madhoun4, Ratna Dwi Puji Astuti1.
Abstract
Air quality deterioration is a major environmental problem in Indonesia. This study evaluated the levels and health risks of potentially toxic elements (PTEs) in Maros Regency, Indonesia. Total suspended particulate matter was collected from industrial areas for PTE (Al, Pb, Cr, Cu, Ni, As and Zn) analysis using inductively coupled plasma optical emission spectrometry (ICP-OES). Samples were collected from six critical areas in the Bantimurung region as that is where marble, cement and limestone industries are located. A calculation of the non-carcinogenic and cancer risks was performed to determine the potential health exposures in adults and children. A Monte Carlo simulation with 10,000 iterations and a sensitivity analysis was carried out to identify the risk probability and the most sensitive variable contributing to cancer risk from PTE exposure in humans. The results showed that the concentration of PTEs decreased in the order of Zn > Al > Cr > Pb > Cu > Ni > As in the wet season, and Zn > Al > Pb > As > Cr > Cu > Ni in the dry season. The hazard index (HI) value for children was 2.12, indicating a high non-carcinogenic risk for children. The total cancer risk (TCR) values in adults and children were 3.11 × 10-5 and 1.32 × 10-4, respectively, implying that both are at risk for developing cancer. The variables with the most contribution to cancer risk from As, Cr and Pb exposure in adults and children were As concentration (33.9% and 41.0%); exposure duration (ED) (34.3%) and SA (40.7%); and SA (98.7 % and 45.4%), respectively. These findings could be used as the scientific basis for public health intervention and to raise awareness of the harmful health effects of particulate bound PTEs.Entities:
Keywords: Maros; air pollution; industrial waste; risk assessment
Year: 2021 PMID: 34941762 PMCID: PMC8708896 DOI: 10.3390/toxics9120328
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Figure 1Map of the study area and sampling locations in Maros Regency.
Definitions, units, symbols and values for the health risk assessment.
| Definitions | Units | Symbols | Values | Sources |
|---|---|---|---|---|
| Metal concentration | mg/m3 for ADDinhalation, and mg.kg−1 | C | Site-specific | |
| Ingestion rate | mg.day−1 |
| 200, children | [ |
| Inhalation rate | m3.day−1 |
| 7.6, children | [ |
| Exposure duration | year | ED | Site-specific | |
| Exposure frequency | days/year | EF | 350 | [ |
| Conversion factor | kg.mg−1 | CF | 1 × 10−6 | [ |
| Body weight | kg | BW | Site-specific | |
| Averaging time | days | AT | ED × 365 days | Site-specific |
| Particulate emission factor | m3/kg | PEF | 1.36 × 109 | [ |
| Dermal absorption factor | ABS | 0.001 | [ | |
| Skin surface area | cm2 | SA | Site-specific | |
| Skin adherence factor | mg.cm−2 h | SL | 0.07, adults | [ |
References doses (RfD), reference concentration (RfC) and cancer slope factor (CSF) from seven metals.
| Metals | Dermal RfD | Ingestion RfD | Inhalation RfC | Ingestion CSF | Dermal CSF | Inhalation CSF | Sources |
|---|---|---|---|---|---|---|---|
| Al | 1.00 × 10−1 | 4.00 × 10−4 | 5.00 × 10−3 | - | - | - | [ |
| As | 3.00 × 10−4 | 3.00 × 10−4 | 3.00 × 10−4 | 1.50 × 10−3 | 1.5 × 10−3 | 1.5 × 10−3 | [ |
| Cr | 6.00 × 10−5 | 3.00 × 10−3 | 8.00 × 10−6 | 5.00 × 10−1 | 4.2 × 10−1 | 41 | [ |
| Cu | 12 | 40 | 1.20 × 10−4 | - | - | - | [ |
| Ni | 5.4 | 20 | 1.40 × 10−2 | - | - | - | [ |
| Pb | 5.20 × 10−4 | 3.50 × 10−3 | 5.20 × 10−4 | 8.50 × 10−3 | 4.2 × 10−1 | 4.2 × 10−2 | [ |
| Zn | 60 | 3.00 × 10−1 | 3.60 × 10−4 | - | - | - | [ |
Metal concentrations in total suspended particulate (μg/m3) in the atmosphere compared to Indonesian and WHO standards.
| TSP | Al | As | Cr | Cu | Ni | Pb | Zn | ||
|---|---|---|---|---|---|---|---|---|---|
| Wet season | Aver | 51.75 | 2558.5 | 1.61 | 11.88 | 4.68 | 1.80 | 6.90 | 9844.5 |
| Min | 6.39 | 6098.8 | 1.45 | 10.71 | 2.72 | 1.44 | 5.54 | 7956.7 | |
| Max | 133.24 | 11,678.8 | 2.08 | 13.95 | 7.04 | 2.13 | 8.11 | 14,632.5 | |
| Std | 43.8 | 2558.5 | 0.24 | 1.25 | 1.64 | 0.30 | 0.90 | 2587.8 | |
| Dry season | Aver | 156.86 | 844.50 | 91.63 | 81.17 | 78.97 | BDL | 746.78 | 23247.1 |
| Min | 8.07 | 58.6 | 51.94 | 8.21 | 4.74 | BDL | 130.33 | 15,139.4 | |
| Max | 94.24 | 1446.66 | 136.81 | 187.8 | 243.7 | BDL | 1968.1 | 30,600.1 | |
| Std | 33.9 | 33.63 | 27.93 | 81.46 | 99.07 | BDL | 918.8 | 7468.7 | |
| Standard | |||||||||
| Indonesian [ | 230 μg/m3 (24 h) | - | - | - | - | - | 2 μg/m3 (24 h) | - | |
| WHO [ | 150–230 μg/m3 (24 h) | - | 6.6 ng/m3 | 0.001 μg/m3 | - | 25 ng/m3 | 0.5 μg/m3 | - | |
BDL: below detection limit.
Hazard quotient (HQ) and hazard index (HI) values from inhalation, ingestion and dermal route.
| Al | As | Cr | Cu | Ni | Pb | Zn | HI | ||
|---|---|---|---|---|---|---|---|---|---|
| Adults | HQInh | 3.88 × 10−4 | 3.55 × 10−4 | 1.32 × 10−2 | 7.96 × 10−4 | 2.93 × 10−7 | 3.61 × 10−8 | 1.05 × 10−1 | 0.64 |
| HQIng | 1.27 × 10−3 | 2.41 × 10−1 | 2.40 × 10−2 | 1.62 × 10−6 | 1.39 × 10−7 | 1.67 × 10−1 | 8.56 × 10−2 | ||
| HQDerm | 5.85 × 10−5 | 4.33 × 10−10 | 4.80 × 10−3 | 2.16 × 10−8 | 2.06 × 10−9 | 4.49 × 10−3 | 1.70 × 10−6 | ||
| Children | HQInh | 2.93 × 10−4 | 2.61 × 10−4 | 9.78 × 10−3 | 5.86 × 10−4 | 2.16 × 10−7 | 2.66 × 10−8 | 7.73 × 10−2 | 2.12 |
| HQIng | 4.94 × 10−3 | 9.36 × 10−1 | 9.34 × 10−2 | 6.29 × 10−6 | 5.42 × 10−7 | 6.48 × 10−1 | 3.32 × 10−1 | ||
| HQDerm | 1.41 × 10−4 | 2.62 × 10−3 | 1.01 × 10−2 | 5.87 × 10−8 | 5.62 × 10−9 | 1.22 × 10−2 | 4.65 × 10−6 |
Carcinogenic risk (CR) and total carcinogenic risk (TCR) for adults and children.
| Routes | As | Pb | Cr | TCR | |
|---|---|---|---|---|---|
| Adults | CRInh | 1.55 × 10−10 | 3.52 × 10−8 | 4.24 × 10−8 | 3.11 × 10−5 |
| CRIng | 1.05 × 10−7 | 2.08 × 10−6 | 2.89 × 10−5 | ||
| CRDerm | 2.41 × 10−11 | 5.46 × 10−8 | 6.58 × 10−9 | ||
| Children | CRInh | 1.14 × 10−10 | 2.60 × 10−8 | 3.14 × 10−8 | 1.32 × 10−4 |
| CRIng | 4.11 × 10−7 | 1.89 × 10−5 | 1.12 × 10−4 | ||
| CRDerm | 1.66 × 10−10 | 3.77 × 10−7 | 4.55 × 10−8 |
Figure 2Sensitivity analysis results for cancer risk estimation in adults and children: (a) cancer risk of As; (b) cancer risk of Cr; and (c) cancer risk of Pb.